Literature DB >> 27098017

Neuroscience-based Nomenclature (NbN) for Journal of Psychopharmacology.

David J Nutt1, Pierre Blier2.   

Abstract

Mesh：

Year:  2016        PMID： 27098017     DOI： 10.1177/0269881116642903

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN： 0269-8811            Impact factor:   4.153


× No keyword cloud information.
  10 in total

1.  Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report.

Authors:  Thitiporn Supasitthumrong; Blanca M Bolea-Alamanac; Selim Asmer; Vincent L Woo; Petal S Abdool; Simon J C Davies
Journal:  Br J Clin Pharmacol       Date:  2019-02-08       Impact factor: 4.335

2.  Neuroscience-based nomenclature and medicolegal significance.

Authors:  Smitha Ramadas
Journal:  Indian J Psychiatry       Date:  2016 Jul-Sep       Impact factor: 1.759

3.  How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysis.

Authors:  Katharina Gutsmiedl; Marc Krause; Irene Bighelli; Johannes Schneider-Thoma; Stefan Leucht
Journal:  BMC Psychiatry       Date:  2020-03-04       Impact factor: 3.630

4.  Effects of long-term antipsychotics treatment on body weight: A population-based cohort study.

Authors:  Juan Carlos Bazo-Alvarez; Tim P Morris; James R Carpenter; Joseph F Hayes; Irene Petersen
Journal:  J Psychopharmacol       Date:  2019-11-14       Impact factor: 4.153

5.  Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age.

Authors:  Leif Hommers; Maike Scherf-Clavel; Roberta Stempel; Julian Roth; Matthias Falter; Jürgen Deckert; Manuel Mattheisen; Stefan Unterecker; Micha Gawlik
Journal:  J Psychopharmacol       Date:  2021-03-28       Impact factor: 4.153

6.  Effects of docosanyl ferulate, a constituent of Withania somnifera, on ethanol- and morphine-elicited conditioned place preference and ERK phosphorylation in the accumbens shell of CD1 mice.

Authors:  Riccardo Maccioni; Marcello Serra; Jacopo Marongiu; Filippo Cottiglia; Elias Maccioni; Valentina Bassareo; Micaela Morelli; Sanjay B Kasture; Elio Acquas
Journal:  Psychopharmacology (Berl)       Date:  2022-01-28       Impact factor: 4.530

7.  Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.

Authors:  Simon Jc Davies; Amer M Burhan; Donna Kim; Philip Gerretsen; Ariel Graff-Guerrero; Vincent L Woo; Sanjeev Kumar; Sarah Colman; Bruce G Pollock; Benoit H Mulsant; Tarek K Rajji
Journal:  J Psychopharmacol       Date:  2018-01-17       Impact factor: 4.153

8.  A Quantitative and Narrative Evaluation of Goodman and Gilman's Pharmacological Basis of Therapeutics.

Authors:  Brian J Piper; Alexandria A Alinea; John R Wroblewski; Sara M Graham; Daniel Y Chung; Livia R M McCutcheon; Melissa A Birkett; Steven S Kheloussi; Vicky M Shah; John L Szarek; Qais K Zalim; John A Arnott; William A McLaughlin; Pamela A Lucchesi; Kimberly A Miller; Gabi N Waite; Michael Bordonaro
Journal:  Pharmacy (Basel)       Date:  2019-12-20

9.  Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports.

Authors:  Stefania Chiappini; Fabrizio Schifano; John Martin Corkery; Amira Guirguis
Journal:  J Psychopharmacol       Date:  2021-01-10       Impact factor: 4.153

10.  High dose antipsychotic polypharmacy and dopamine partial agonists - time to rethink guidelines?

Authors:  Gavin P Reynolds
Journal:  J Psychopharmacol       Date:  2021-07-14       Impact factor: 4.153
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.